Scott Braunstein

Dr. Braunstein serves as an Operating Partner at Aisling Capital. He recently served as Chief Operating Officer at Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. During his tenure at Pacira, his role included SVP of Strategy; Chief Strategy Officer, and Chief Operating Officer.

Dr. Braunstein was appointed to the Esperion Board of Directors in June 2015. He has served as member of the Audit Committee since joining Esperion as well as Chairman of the Audit Committee for the past 2 years. Scott serves as Chairman of the Board of Artara Therapeutics and joined the boards and audit committees of Trevena, Marinus, and Ziopharm in 2018.

Earlier in his career, Dr. Braunstein served as a healthcare portfolio manager at Everpoint Asset Management. Previously, he spent 12 years with J.P. Morgan Asset Management as a healthcare analyst and managing director in the U.S. Equity team, and as a portfolio manager in the Global Healthcare team responsible for managing investments in pharmaceuticals, biotechnology, and medical devices. From 2000 until 2002 he was in healthcare specialty sales at Deutsche Bank. Prior to that, Dr. Braunstein was Vice President of Operations at Defined Healthcare.

Dr. Braunstein began his career as a practicing physician at the Summit Medical Group and as Assistant Clinical Professor at Albert Einstein College of Medicine and for Columbia University Medical Center after completing his training at the New York Hospital/Cornell Medical Center, his research experience at Rockefeller University.